122 related articles for article (PubMed ID: 17142325)
1. FHIT-proteasome degradation caused by mitogenic stimulation of the EGF receptor family in cancer cells.
Bianchi F; Magnifico A; Olgiati C; Zanesi N; Pekarsky Y; Tagliabue E; Croce CM; Ménard S; Campiglio M
Proc Natl Acad Sci U S A; 2006 Dec; 103(50):18981-6. PubMed ID: 17142325
[TBL] [Abstract][Full Text] [Related]
2. Fhit Nuclear Import Following EGF Stimulation Sustains Proliferation of Breast Cancer Cells.
Bianchi F; Sasso M; Turdo F; Beretta GL; Casalini P; Ghirelli C; Sfondrini L; Ménard S; Tagliabue E; Campiglio M
J Cell Physiol; 2015 Nov; 230(11):2661-70. PubMed ID: 25711523
[TBL] [Abstract][Full Text] [Related]
3. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
Huang Y; Li X; Jiang J; Frank SJ
Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
[TBL] [Abstract][Full Text] [Related]
4. EGF receptor-mediated, c-Src-dependent, activation of Stat5b is downregulated in mitogenically responsive hepatocytes.
Guren TK; Ødegård J; Abrahamsen H; Thoresen GH; Susa M; Andersson Y; Østby E; Christoffersen T
J Cell Physiol; 2003 Jul; 196(1):113-23. PubMed ID: 12767047
[TBL] [Abstract][Full Text] [Related]
5. Csk-binding protein (Cbp) negatively regulates epidermal growth factor-induced cell transformation by controlling Src activation.
Jiang LQ; Feng X; Zhou W; Knyazev PG; Ullrich A; Chen Z
Oncogene; 2006 Sep; 25(40):5495-506. PubMed ID: 16636672
[TBL] [Abstract][Full Text] [Related]
6. Activated Src and Ras induce gefitinib resistance by activation of signaling pathways downstream of epidermal growth factor receptor in human gallbladder adenocarcinoma cells.
Qin B; Ariyama H; Baba E; Tanaka R; Kusaba H; Harada M; Nakano S
Cancer Chemother Pharmacol; 2006 Nov; 58(5):577-84. PubMed ID: 16532343
[TBL] [Abstract][Full Text] [Related]
7. Dok-R mediates attenuation of epidermal growth factor-dependent mitogen-activated protein kinase and Akt activation through processive recruitment of c-Src and Csk.
Van Slyke P; Coll ML; Master Z; Kim H; Filmus J; Dumont DJ
Mol Cell Biol; 2005 May; 25(9):3831-41. PubMed ID: 15831486
[TBL] [Abstract][Full Text] [Related]
8. SRC family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cells.
Zhang Q; Thomas SM; Xi S; Smithgall TE; Siegfried JM; Kamens J; Gooding WE; Grandis JR
Cancer Res; 2004 Sep; 64(17):6166-73. PubMed ID: 15342401
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of the human Fhit tumor suppressor on tyrosine 114 in Escherichia coli and unexpected steady state kinetics of the phosphorylated forms.
Garrison PN; Robinson AK; Pekarsky Y; Croce CM; Barnes LD
Biochemistry; 2005 Apr; 44(16):6286-92. PubMed ID: 15835917
[TBL] [Abstract][Full Text] [Related]
10. Activation of tyrosine kinases by alpha1A-adrenergic and growth factor receptors in transfected PC12 cells.
Zhong H; Minneman KP
Biochem J; 1999 Dec; 344 Pt 3(Pt 3):889-94. PubMed ID: 10585878
[TBL] [Abstract][Full Text] [Related]
11. Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action.
Migliaccio A; Di Domenico M; Castoria G; Nanayakkara M; Lombardi M; de Falco A; Bilancio A; Varricchio L; Ciociola A; Auricchio F
Cancer Res; 2005 Nov; 65(22):10585-93. PubMed ID: 16288052
[TBL] [Abstract][Full Text] [Related]
12. An EGF receptor/Ral-GTPase signaling cascade regulates c-Src activity and substrate specificity.
Goi T; Shipitsin M; Lu Z; Foster DA; Klinz SG; Feig LA
EMBO J; 2000 Feb; 19(4):623-30. PubMed ID: 10675331
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of a cytoskeleton-associated, epidermal growth factor sensitive pp60c-src substrate.
Maa MC; Wilson LK; Moyers JS; Vines RR; Parsons JT; Parsons SJ
Oncogene; 1992 Dec; 7(12):2429-38. PubMed ID: 1281304
[TBL] [Abstract][Full Text] [Related]
14. Activation of erbB2 and c-src in phorbol ester-treated mouse epidermis: possible role in mouse skin tumor promotion.
Xian W; Rosenberg MP; DiGiovanni J
Oncogene; 1997 Mar; 14(12):1435-44. PubMed ID: 9136987
[TBL] [Abstract][Full Text] [Related]
15. Restoration of fragile histidine triad expression restores Chk2 activity in response to ionizing radiation in oral squamous cell carcinoma cells.
Yutori H; Semba S; Komori T; Yokozaki H
Cancer Sci; 2008 Mar; 99(3):524-30. PubMed ID: 18167129
[TBL] [Abstract][Full Text] [Related]
16. Activation of Gαq subunits up-regulates the expression of the tumor suppressor Fhit.
Zuo H; Chan AS; Ammer H; Wong YH
Cell Signal; 2013 Dec; 25(12):2440-52. PubMed ID: 23993961
[TBL] [Abstract][Full Text] [Related]
17. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.
Song L; Turkson J; Karras JG; Jove R; Haura EB
Oncogene; 2003 Jul; 22(27):4150-65. PubMed ID: 12833138
[TBL] [Abstract][Full Text] [Related]
18. Fhit protein inhibits cell growth by attenuating the signaling mediated by nuclear factor-kappaB in colon cancer cell lines.
Nakagawa Y; Akao Y
Exp Cell Res; 2006 Aug; 312(13):2433-42. PubMed ID: 16733051
[TBL] [Abstract][Full Text] [Related]
19. The protein kinase C inhibitor Go6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] potentiates agonist-induced mitogen-activated protein kinase activation through tyrosine phosphorylation of the epidermal growth factor receptor.
Shah BH; Olivares-Reyes JA; Catt KJ
Mol Pharmacol; 2005 Jan; 67(1):184-94. PubMed ID: 15465928
[TBL] [Abstract][Full Text] [Related]
20. Activation state-dependent interaction between Gαq subunits and the Fhit tumor suppressor.
Zuo H; Chan GP; Zhu J; Yeung WW; Chan AS; Ammer H; Wong YH
Cell Commun Signal; 2013 Aug; 11():59. PubMed ID: 23947369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]